FDA Clears New Enzyme Replacement Therapy For Pompe Disease
The US Food and Drug Administration (FDA) has supported another compound substitution treatment, avalglucosidase alfa (Nexviazyme, Genzyme), for patients matured 1 year and more seasoned … Read more